Johnstone, D., Limacher, M., Rousseau, M., Liang, C.S., Ekelund, L., Herman, M., Stewart, D., Guillotte, M., Bjerken, G. and Gaasch, W. (1992) Clinical characteris- tics of patients in studies of left ventricular dysfunction (SOLVD). American Journal of Cardiology, 70, 894-900. doi:10.1016/0002-9149(92)90734-G [20] Packer, M., Poole-Wilson, P.A., Armstrong, P.W., Cleland, J.G., Horowitz, J.D., Massie, B.M., Rydén, L., Thygesen, K. and Uretsky, B.F. (1999) Comparative effects of low and high doses of the angio-tensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation, 100, 2312-2318. doi:10.1161/01.CIR.100.23.2312 [21] Singh, S.N., Fletcher, R.D., Fisher, S.G., Singh, B.N., Lewis, H.D., Deedwania, P.C., Massie, B.M., Colling, C. and Lazzeri, D. (1995) Amiodarone in patients with con- gestive heart failure and asymptomatic ventricular arrhy- thmia. Survival trial of antiarrhythmic therapy in congestive heart failure. The New England Journal of Medicine, 333, 77-82. doi:10.1056/NEJM199507133330201 [22] (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scan-dinavian enalapril survival study (CONSENSUS). The CONSENSUS Trial Study Group. The New England Journal of Medicine, 316, 1429-1435. doi:10.1056/NEJM198706043162301 [23] Yusuf, S., Pepine, C.J., Garces, C., Pouleur, H., Salem, D., Kostis, J., Benedict, C., Rousseau, M., Bourassa, M. and Pitt, B. (1992) Effect of enalapril on myocardial in- farction and unstable angina in patients with low ejection fractions. The Lancet, 340, 1173-1178. doi:10.1016/0140-6736(92)92889-N [24] Tsang, T.S., Gersh, B.J., Appleton, C.P., Tajik, A.J., Barnes, M.E., Bailey, K.R., Oh, J.K., Leibson C, Montgom- ery, S.C. and Seward, J.B. (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. Journal of the American College of Cardiology, 40, 1636-1644. doi:10.1016/S0735-1097(02)02373-2 [25] Shinbane, J.S., et al. (1997) Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. Journal of the American College of Cardiology, 29, 709-15. doi:10.1016/S0735-1097(96)00592-X [26] Pozzoli, M., et al. (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm. Journal of the American College of Cardiology, 32, 197- 204. doi:10.1016/S0735-1097(98)00221-6 [27] Li, D., et al. (1999) Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation, 100, 87-95. doi:10.1161/01.CIR.100.1.87 [28] Sanders, P., et al. (2003) Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation, 108, 1461-1468. doi:10.1161/01.CIR.0000090688.49283.67 [29] Sparks, P.B., et al. (1999) Electrical remodeling of the atria following loss of atrioventricular synchrony: A long- term study in humans. Circulation, 100, 1894-1900. doi:10.1161/01.CIR.100.18.1894 [30] John, B., et al. (2010) Reverse remodeling of the atria after treatment of chronic stretch in humans: Implications for the atrial fibrillation substrate. Journal of the Ameri- can College of Cardiology, 55, 1217-1226. doi:10.1016/j.jacc.2009.10.046 [31] Sanders, P., et al. (2003) Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: Implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation, 108, 1976-1984. doi:10.1161/01.CIR.0000091408.45747.04 [32] Wilton, S.B. (2010) Investigation of non-pharmacological therapies in patients with heart failure and atrial fibrillation, University of Calgary, Calgary. [33] Mamas, M.A., et al. (2009) A meta-analysis of the prog- nostic significance of atrial fibrillation in chronic heart failure. European Journal of Heart Failure, 11, 676-683. doi:10.1093/eurjhf/hfp085 [34] Hagens, V.E., et al. (2005) Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte control versus electrical cardioversion (RACE) study. American Heart Journal, 149, 1106-1111. doi:10.1016/j.ahj.2004.11.030 [35] Roy, D., et al. (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. The New England Journal of Medicine, 358, 2667-2677. doi:10.1056/NEJMoa0708789 [36] Kober, L., Torp-Pedersen, C., McMurray, J.J., et al. (2008) Increased mortality after dronedarone therapy for severe heart failure. The New England Journal of Medicine, 358, 2678-2687. doi:10.1056/NEJMoa0800456 [37] Bardy, G.H., et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352, 225-237. doi:10.1056/NEJMoa043399 [38] Flaker, G.C., et al. (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The stroke prevention in atrial fibrillation investigators. Journal of the American College of Cardiology, 20, 527-532. doi:10.1016/0735-1097(92)90003-6 [39] Kaufman, E.S., et al. (2004) Risk of proarrhythmic events in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: A multivariate analysis. Journal of the American College of Cardiology, 44, 1276- 1282. [40] Torp-Pedersen, C., et al. (2007) The safety of amiodarone in patients with heart failure. Journal of Cardiac Failure, 13, 340-345. doi:10.1016/j.cardfail.2007.02.009 [41] Wyse, D.G., et al. (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine, 347, 1825-1833. doi:10.1056/NEJMoa021328 [42] Corley, S.D., et al. (2004) Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation, 109, 1509-1513. doi:10.1161/01.CIR.0000121736.16643.11 [43] Pedersen, O.D., et al. (2001) Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (diamond) sub-study. Circulation, 104, 292-296. doi:10.1161/01.CIR.104.3.292 [44] Deedwania, P.C., Singh, B.N., Ellenbogen, K., Fisher, S., Fletcher, R. and Singh, S.N. (1998) Spontaneous con- version and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation, 98, 2574-2579. doi:10.1161/01.CIR.98.23.2574 [45] Shelton, R.J., et al. (2009) A randomised, controlled study of rate versus rhythm control in patients with chro- nic atrial fibrillation and heart failure: (CAFE-II study). Heart, 95, 924-930. doi:10.1136/hrt.2008.158931 [46] Haissaguerre, M., et al. (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine, 339, 659-666. doi:10.1056/NEJM199809033391003 [47] McKenna, C., et al. (2009) Cost-effectiveness of radio-frequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart, 95, 542-549. doi:10.1136/hrt.2008.147165 [48] Cappato, R., et al. (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation: Arrhythmia and Electrophysiology, 3, 32-38. doi:10.1161/CIRCEP.109.859116 [49] Nair, G.M., Nery, P.B., Diwakaramenon, S., Healey, J.S., Connolly, S.J. and Morillo, C.A. (2009) A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20, 138-144. doi:10.1111/j.1540-8167.2008.01285.x [50] Wilber, D.J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E.G., Cal- kins, H., Hall, B., Reddy, V., Augello, G., Reynolds, M.R., Vinekar, C., Liu, C.Y., Berry, S.M., Berry, D.A. and ThermoCool AF Trial Investigators (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA, 303, 333-340. doi:10.1001/jama.2009.2029 [51] Anter, E., Jessup, M. and Callans, D.J. (2009) Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation, 119, 2516-2525. doi:10.1161/CIRCULATIONAHA.108.821306 [52] Themistoclakis, S., Corrado, A., Marchlinski, F.E., Jais, P., Zado, E., Rossillo, A., et al. (2010) The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. Journal of the American College of Cardiology, 55, 735-743. doi:10.1016/j.jacc.2009.11.039 [53] Dagres, N., Hindricks, G., Kottkamp, H., Sommer, P., Gaspar, T., Bode, K., et al. (2009) Complications of atrial fibrillation ablation in a high-volume center in 1000 procedures: Still cause for concern? Journal of Cardiovascular Electrophysiology, 20, 1014-1019. doi:10.1111/j.1540-8167.2009.01493.x [54] Tilz, R.R., Chun, K.R., Schmidt, B., Fuernkranz, A., Wissner, E., Koester, I., et al. (2010) Catheter ablation of long-standing persistent atrial fibrillation: A lesson from circumferential pulmonary vein isolation. Journal of Cardiovascular Electrophysiology, 21, 1085-1093. doi:10.1111/j.1540-8167.2010.01799.x [55] Chen, M.S., Marrouche, N.F., Khaykin, Y., Gillinov, A.M., Wazni, O., Martin, D.O., et al. (2004) Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. Journal of the American College of Cardiology, 43, 1004-1009. doi:10.1016/j.jacc.2003.09.056 [56] Hsu, L.F., Ja€?s, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., et al. (2004) Catheter ablation for atrial fibril- lation in congestive heart failure. The New England Jour- nal of Medicine, 351, 2373-2378. doi:10.1056/NEJMoa041018 [57] Tondo, C., Mantica, M., Russo, G., Avella, A., De Luca, L., Pappalardo, A., Fagundes, R.L., Picchio, E., Laurenzi, F., Piazza, V. and Bisceglia, I. (2006) Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing and Clinical Electrophysiology, 29, 962-970. doi:10.1111/j.1540-8159.2006.00471.x [58] Gentlesk, P.J., Sauer, W.H., Gerstenfeld, E.P., Lin, D., Dixit, S., Zado, E., et al. (2007) Reversal of left ventricu- lar dysfunction following ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 18, 9-14. doi:10.1111/j.1540-8167.2006.00653.x [59] Efremidis, M., Sideris, A., Xydonas, S., Letsas, K.P., Alexanian, I.P., Manolatos, D., et al. (2008) Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. The Hellenic Journal of Cardiology, 49, 19-25. [60] Nademanee, K., Schwab, M.C., Kosar, E.M., Karwecki, M., Moran, M.D., Visessook, N., Michael, A.D. and Ngarmukos, T. (2008) Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. Journal of the American College of Cardiology, 51, 843- 849. doi:10.1016/j.jacc.2007.10.044 [61] Lutomsky, B.A., Rostock, T., Koops, A., Steven, D., M€ullerleile, K., Servatius, H., et al. (2008) Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace, 10, 593-599. doi:10.1093/europace/eun076 [62] De Potter, T., Berruezo, A., Mont, L., Matiello, M., Tamborero, D., Santibanez, C., et al. (2010) Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace, 12, 24-29. doi:10.1093/europace/eup309 [63] Choi, A.D., Hematpour, K., Kukin, M., Mittal, S. and Steinberg, J.S. (2010) Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ven- tricular dysfunction. Congestive Heart Failure, 16, 10-14. doi:10.1111/j.1751-7133.2009.00116.x [64] Cha, Y.M., Wokhlu, A., Asirvatham, S.J., Shen, W.K., Friedman, P.A., Munger, T.M., Oh, J.K., Monahan, K.H., Haroldson, J.M., Hodge, D.O., Herges, R.M., Hammill, S.C. and Packer, D.L. (2011) Success of ablation for atrial fibrillation in isolated left ventricular diastolic dys-function: A comparison to systolic dysfunction and normal ventricular function. Circulation: Arrhythmia and Electrophysiology, 4, 742-32. [65] Khan, M.N., Ja?s, P., Cummings, J., Di Biase, L., Sanders, P., Martin, D.O., et al. (2008) Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine, 359, 1778-1785. doi:10.1056/NEJMoa0708234 [66] MacDonald, M.R., Connelly, D.T., Hawkins, N.M., Steedman, T., Payne, J., Shaw, M., et al. (2011) Radio-frequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: A randomised controlled trial. Heart, 97, 740-747. doi:10.1136/hrt.2010.207340 [67] Wilton, S.B., Fundytus, A., Ghali, W.A., Veenhuyzen, G.D., Quinn, F.R., Mitchell, L.B., Hill, M.D., Faris, P. and Exner, D.V. (2010) Meta-analysis of the effective- ness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. American Journal of Cardiology, 106, 1284-1291. doi:10.1016/j.amjcard.2010.06.053 [68] Dagres, N., Varounis, C., Gaspar, T., Piorkowski, C., Eitel, C., Iliodromitis, E.K., Lekakis, J.P., Flevari, P., Simeonidou, E., Rallidis, L.S., Tsougos, E., Hindricks, G., Sommer, P. and Anastasiou-Nana, M. (2011) Catheter ab- lation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-ana- lysis. Journal of Cardiac Failure, 17, 964-970. doi:10.1016/j.cardfail.2011.07.009 [69] St. Luke’s-Roosevelt Hospital Center (2011) Pulmonary vein isolation for rhythm control in patients with atrial fibrillation and left ventricular dysfunction: A pilot study. ClinicalTrials.gov identifier: NCT01082601. [70] Barts & The London NHS Trust (2010) Catheter ablation versus medical treatment of AF in heart failure (CAM- TAF). ClinicalTrials.gov identifier: NCT01411371 [71] Royal Brompton & Harefield NHS Foundation Trust (2012) Catheter ablation versus medical rate control for atrial fibrillation in patients with heart failure (ARC-HF). ClinicalTrials.gov identifier: NCT00878384 [72] St. Jude Medical (2012) Atrial fibrillation management in congestive heart failure with ablation (AMICA). ClinicalTrials.gov identifier: NCT00652522 [73] Marrouche, N.F., Brachmann, J. and CASTLE-AF Steering Committee (2009) Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF)—Study design. Pacing and Clinical Electrophysiology, 32, 987-994. doi:10.1111/j.1540-8159.2009.02428.x [74] University of Ottawa Heart Institute (2012) Rate versus catheter ablation rhythm control in patients with heart failure and high burden atrial fibrillation (RAFT-AF). ClinicalTrials.gov identifier: NCT01420393.

  
comments powered by Disqus
WJCD Subscription
E-Mail Alert
WJCD Most popular papers
Publication Ethics & OA Statement
WJCD News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.